PMID-15996790 – Discovery Melanocortin Regulates Sexual Functions
Hadley ME. "Discovery that a melanocortin regulates sexual functions in male and female humans," Peptides, 2005;26(10):1687-1689.
Quick Reference
| Property | Value |
|---|---|
| PMID | 15996790 |
| DOI | 10.1016/j.peptides.2005.01.023 |
| Year | 2005 |
| Journal | Peptides |
| Study Type | Narrative Review |
| Evidence Level | V |
| Sample | N/A (historical perspective) |
| Peptide(s) Studied | Melanotan II |
Key Findings
- First-person historical account by Mac Hadley, co-developer of Melanotan II at the University of Arizona
- Sexual effects of MT-II were discovered accidentally during tanning dose-escalation studies
- A researcher self-injecting MT-II experienced a spontaneous, prolonged erection — the first observation of melanocortin-induced sexual arousal in humans
- This serendipitous discovery redirected the entire melanocortin field toward sexual function research
- Hadley traces the path from alpha-MSH analog chemistry to the clinical development of bremelanotide (PT-141)
- Emphasizes that MT-II's sexual effects are centrally mediated (brain) rather than peripherally mediated (genitalia)
- Notes that the central mechanism is fundamentally different from PDE5 inhibitors like Viagra
- Highlights the broad potential of melanocortin receptors as drug targets for multiple indications
Study Design
Personal historical narrative and perspective piece by one of the original MT-II developers. Recounts the discovery timeline, key observations, and conceptual framework that led from a tanning peptide to a sexual health therapeutic.
Limitations
- Personal account, not systematic review or primary data
- Single author perspective; may not capture full development history
- Published as a short communication; limited detail on methodology
- Historical context from the early 2000s; clinical landscape has since evolved substantially
Clinical Relevance
This paper provides essential historical context for understanding the melanocortin peptide class. The accidental discovery narrative illustrates why MT-II has both tanning and sexual effects (MC1R for pigmentation, MC4R for sexual function). For practitioners and educators, this is a key reference for explaining the pharmacological rationale behind Melanotan II and PT-141 to patients: these peptides were designed for pigmentation but their most clinically significant effects operate through a distinct receptor in the brain's sexual arousal circuits.
Related
#research #narrative-review #evidence-level-V